4//SEC Filing
KOLINSKI STUART 4
Accession 0001237899-10-000013
CIK 0000872589other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:10 PM ET
Size
9.2 KB
Accession
0001237899-10-000013
Insider Transaction Report
Form 4
KOLINSKI STUART
SVP General Counsel and Secret
Transactions
- Sale
Common Stock
2010-01-27$27.00/sh−4,359$117,693→ 10,613 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2010-01-27−4,359→ 0 totalExercise: $8.50Exp: 2011-01-05→ Common Stock (4,359 underlying) - Exercise/Conversion
Common Stock
2010-01-27$8.50/sh+4,359$37,052→ 14,972 total
Holdings
- 3,294(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- [F3]Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001226686
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 4:10 PM ET
- Size
- 9.2 KB